Genome-wide Haplotype Association Analysis in Mental Disorders
精神疾病的全基因组单倍型关联分析
基本信息
- 批准号:7656015
- 负责人:
- 金额:$ 37.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAttention deficit hyperactivity disorderAutistic DisorderBiologicalBipolar DisorderBypassClassificationComplexDataDetectionDevelopmentDiagnosticDiseaseDrug FormulationsEnsureEnvironmental Risk FactorEquilibriumEvaluationExhibitsFaceFoundationsGenesGeneticGenetic DeterminismGenetic PolymorphismGenetic Predisposition to DiseaseGenomeGenomicsGoalsHaplotypesHealthHereditary DiseaseHumanInflammatoryLeadMajor Depressive DisorderMediatingMental disordersMethodologyMethodsModelingMutationPathogenesisPatternPerformancePredispositionPreventionProceduresProcessPsyche structurePublishingReportingResearch DesignResearch PersonnelSchizophreniaScientistScreening procedureSignal TransductionSolidStagingStatistical ModelsTechniquesTherapeuticVariantWorkadvanced diseaseanalytical toolbasecase controlcomputer programcostdepressiondesignfollow-upgenetic variantgenome wide association studygenome-widegenotyping technologyimprovedinsightnovelpublic health relevanceresponsesimulationsuccesstooltraittreatment responsetreatment strategyuser friendly software
项目摘要
DESCRIPTION (provided by applicant): Mental diseases such as schizophrenia and depression are complex diseases for which susceptibility, development and treatment response are mediated by intricate genetic and environmental factors. Understanding the genetics of these diseases can illuminate significant insights into the development of diagnostics, pathogenesis and therapeutics of these diseases. With recent advancements in comprehensive genomic information and cost-effective genotyping technologies, genome-wide association studies (GWAS) have become a promising new tool for identifying modest genetic determinants of complex disorders. However, GWAS for psychiatric disorders have yet to bring definitive findings. Insufficient power to detect small-effect genes and inability to incorporate complex interactions are the two major attributes for lack of replicable findings. To ensure further success of GWAS, advanced analytical tools and strategies are needed to resolve these issues. This proposal intends to develop methodology in response to this need. Our long-term goal is to advance the efficacy of complex multimarker analysis and eventually to facilitate study design and marker selection. Modeling multimarker polymorphisms provides maximal amount of genomic information, and complex statistical modeling allows careful and collective consideration of potential genetic and environmental factors. In this proposal we focus on model-based haplotype analysis, and propose a two-stage framework to detect and to comprehend the association signals in GWAS. The first stage aims to effectively screen out regions with global haplotype-trait association. The second stage focuses on a more systematic examination of the specific patterns of haplotype effects. Motivated by issues arising in the collaborative works by the investigators, the central considerations of our methodology development include: (a) the efficient usage of haplotype information, (b) the formulation of regression-based framework, (c) the capacity to detect main and interaction effects, (d) a systematic inference progression from initial global screening to follow-up specific evaluation, and (e) the establishment of a solid theoretical foundation and robust implementation in user-friendly software. We will achieve our objectives through the following three specific aims: (1) to develop regression-based haplotype-similarity methods for detecting regions that exhibit genetic main and/or interaction effects, (2) to develop a penalized-likelihood regression approach for characterizing haplotypes of significant main and/or interaction effects within the identified regions, and (3) to apply the methods from aims (1) and (2) to the collaborative GWAS of mental disorders for method evaluation and disease gene detection, and to develop and distribute computer programs for public use.
PUBLIC HEALTH RELEVANCE: Completion of the proposed work will provide effective statistical tools for a new process of studying the genetic etiology of complex diseases, from initial genome screening to subsequent explanatory examination. These tools can facilitate scientists' understanding of complex diseases and eventually lead to better design of prevention, detection and treatment strategies to improve human health.
描述(由申请人提供):精神分裂症和抑郁症等精神疾病是复杂的疾病,其易感性、发展和治疗反应由复杂的遗传和环境因素介导。了解这些疾病的遗传学可以阐明这些疾病的诊断,发病机制和治疗方法的发展有意义的见解。随着全面基因组信息和成本效益基因分型技术的最新进展,全基因组关联研究(GWAS)已成为一种有前途的新工具,用于确定复杂疾病的适度遗传决定因素。然而,GWAS对精神疾病的研究还没有得出明确的结果。检测小效应基因的能力不足和无法整合复杂的相互作用是缺乏可复制发现的两个主要属性。为了确保全球WAS的进一步成功,需要先进的分析工具和战略来解决这些问题。本提案旨在针对这一需要制定方法。我们的长期目标是提高复杂多标记分析的有效性,并最终促进研究设计和标记选择。多标记多态性建模提供了最大量的基因组信息,复杂的统计建模允许仔细和集体考虑潜在的遗传和环境因素。在这个建议中,我们专注于基于模型的单倍型分析,并提出了一个两阶段的框架来检测和理解GWAS中的关联信号。第一阶段旨在有效筛选出具有全局单倍型-性状关联的区域。第二阶段的重点是更系统的检查单倍型效应的具体模式。受调查人员合作工作中出现的问题的启发,我们方法开发的主要考虑因素包括:(a)单倍型信息的有效利用,(B)基于回归的框架的形成,(c)检测主效应和相互作用效应的能力,(d)从初始全局筛选到后续特定评估的系统推理进展,及(e)建立稳固的理论基础,并以方便用户的软件稳健地执行。我们将通过以下三个具体目标实现我们的目标:(1)开发基于回归的单倍型相似性方法,用于检测表现出遗传主效应和/或互作效应的区域,(2)开发惩罚似然回归方法,用于表征鉴定区域内显著主效应和/或互作效应的单倍型,(3)将目标(1)和(2)中的方法应用于精神障碍的协作GWAS,进行方法评估和疾病基因检测,并开发和分发计算机程序供公众使用。
公共卫生关系:拟议工作的完成将为研究复杂疾病遗传病因的新进程提供有效的统计工具,从最初的基因组筛选到随后的解释性检查。这些工具可以促进科学家对复杂疾病的了解,并最终导致更好地设计预防、检测和治疗策略,以改善人类健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jung-Ying Tzeng其他文献
Jung-Ying Tzeng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jung-Ying Tzeng', 18)}}的其他基金
Genome-wide Haplotype Association Analysis in Mental Disorders
精神疾病的全基因组单倍型关联分析
- 批准号:
8052907 - 财政年份:2009
- 资助金额:
$ 37.97万 - 项目类别:
Genome-wide Haplotype Association Analysis in Mental Disorders
精神疾病的全基因组单倍型关联分析
- 批准号:
7793595 - 财政年份:2009
- 资助金额:
$ 37.97万 - 项目类别:
相似海外基金
Understanding the relationship between cannabis use and attention-deficit/hyperactivity disorder
了解大麻使用与注意力缺陷/多动症之间的关系
- 批准号:
2874883 - 财政年份:2023
- 资助金额:
$ 37.97万 - 项目类别:
Studentship
RestEaze: A Novel Wearable Device and Mobile Application to Improve the Diagnosis and Management of Restless Legs Syndrome in Pediatric Patients with Attention Deficit/Hyperactivity Disorder
RestEaze:一种新型可穿戴设备和移动应用程序,可改善注意力缺陷/多动症儿科患者不宁腿综合症的诊断和管理
- 批准号:
10760442 - 财政年份:2023
- 资助金额:
$ 37.97万 - 项目类别:
Diagnosis and Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Workshop
成人注意力缺陷/多动症的诊断和治疗:研讨会
- 批准号:
10825708 - 财政年份:2023
- 资助金额:
$ 37.97万 - 项目类别:
Maternal Attention Deficit Hyperactivity Disorder (m-ADHD): Mental Health, Pregnancy and Infant Outcomes
母亲注意力缺陷多动障碍 (m-ADHD):心理健康、妊娠和婴儿结局
- 批准号:
488888 - 财政年份:2023
- 资助金额:
$ 37.97万 - 项目类别:
Operating Grants
SBIR Phase I: A novel caregiver-centered mobile app and artificial intelligence (AI) coaching intervention for pediatric Attention Deficit Hyperactivity Disorder (ADHD)
SBIR 第一阶段:一款新颖的以护理人员为中心的移动应用程序和人工智能 (AI) 辅导干预儿童注意力缺陷多动障碍 (ADHD)
- 批准号:
2335539 - 财政年份:2023
- 资助金额:
$ 37.97万 - 项目类别:
Standard Grant
Machine Learning Methods to Develop and Deploy Real-Time Risk Surveillance for Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder from the Electronic Health Record
用于开发和部署电子健康记录中自闭症谱系障碍和注意力缺陷多动障碍实时风险监测的机器学习方法
- 批准号:
10449468 - 财政年份:2022
- 资助金额:
$ 37.97万 - 项目类别:
Defining Embodied Characteristics of Decision Making in Attention Deficit Hyperactivity Disorder
定义注意力缺陷多动障碍决策的具体特征
- 批准号:
10316100 - 财政年份:2022
- 资助金额:
$ 37.97万 - 项目类别:
Do Cerebrovascular Factors mediate the possible link between later-life Attention-Deficit/Hyperactivity Disorder and the development of Lewy Body Diseases?
脑血管因素是否介导晚年注意力缺陷/多动障碍与路易体疾病发展之间的可能联系?
- 批准号:
460431 - 财政年份:2022
- 资助金额:
$ 37.97万 - 项目类别:
The biological connection between educational attainment and attention-deficit/hyperactivity disorder in contrasting environments
对比环境中教育程度与注意力缺陷/多动症之间的生物学联系
- 批准号:
10677008 - 财政年份:2022
- 资助金额:
$ 37.97万 - 项目类别:
Conceptualising and Measuring Attention-Deficit Hyperactivity Disorder (ADHD) Across the Lifespan
在整个生命周期中概念化和测量注意力缺陷多动障碍 (ADHD)
- 批准号:
2689864 - 财政年份:2022
- 资助金额:
$ 37.97万 - 项目类别:
Studentship